Please login to the form below
Novartis myeloma drug clears phase III trial
Panobinostat on course to be first in new class of treatment for bone marrow cancer
European Court may yet force AbbVie and InterMune to release data
Orders rethink on EMA's Humira and Esbriet injunction
Pfizer ups the ante on clinical transparency
Revamps access to data portal
Lilly depression drug fails late-stage trials
Will not pursue edivoxetine as an add-on treatment for depression
NICE wants more info on Genzyme's MS drug
UK health guidance body turns down Lemtrada in draft guidance
Pharma's return on R&D spend continues to slide
And cost of launching new medicine rises to $1.3bn says report
IMS Health acquires HGS Europe
Founders Graeme and Angela McFarlane bring HGS' market access services to IMS' UK team
Teva expects big things from improved drug programme
Aims to market enhanced versions of existing medicines
Smart Glasses: A new look for healthcare?
Wearable computer devices like Google Glass are tipped to become the next big technology trend, and have exciting health applications
-
Counting what countsMeasurement is the lifeblood of communications and brand investment in analytics is poised for steep growth
-
Pharma should not ignore IndiaIt’s complicated, but multinational pharma cannot ignore a market with one billion plus people
-
Roche signs $1bn-plus cancer deal with Molecular PartnersPartnership could create new type of drug conjugate similar to ADCs
-
Publicis buys South Africa’s SynergizeComms group acquires African digital search marketing company
-
EU discusses action on stroke preventionStakeholders meet at European Parliament
-
AZ said to be eyeing Forest takeover bidFinancial Times says pharma companies are in early negotiations
-
Celgene signs $3.3bn cancer deal with OncoMedIncludes lead candidate demcizumab
-
EMA: more fee reductions for orphan drugsGreater incentives introduced for larger companies
-
Sanofi's Lantus successor on trackPositive late-stage data for U300 insulin in type 2 diabetes patients
Latest appointments
-
Pfizer's Jonathan Emms to be ABPI presidentWill take over from MSD's Deepak Khanna in April
-
Evoke Pharma adds to executive teamAppoints new chief medical officer and senior director of clinical operations
-
Janssen’s UK head moves to ChinaCesar Rodriguez appointed managing director of Xian Janssen
-
Senior appointment for FleishmanHillardJerry Tolk joins the Atlanta office as senior vice president
-
Lundbeck names SVP for business development and HRJacob Tolstrup is promoted at Danish pharma company
Featured jobs
- Global Brand Manager
- flexible salary + bonus + car allowance + benefits
- Brand Director - Highly Specialised Product - Global remit
- Highly Competitive Basic, Bonus + Benefits
- Commercial Manager
- Negotiable
- Regulatory Affairs Senior Manager, CMC - 12 month cotnract
- Competitive
Subscribe to our email news alerts
Latest intelligence
- Doctors’ disease knowledge: an insight into Latin America
- A lack of specialists outside major cities means many major illnesses go undiagnosed...
- Survey: Digital Futures 2014
- Can you help us predict pharma's digital future?...
- Adherence to treatment and side effect management in breast cancer
- The success of treatment for breast cancer is dependent on a high level of adherence, however it is surprisingly common for women with breast cancer to miss doses or stop...
Quick links
